Sandoz Group AG (SDZ)

Currency in CHF
72.78
+3.60(+5.20%)
Closed·
Advertisement
SDZ is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
69.2272.98
52 wk Range
43.8674.72
Key Statistics
Bid/Ask
72.00 / 72.96
Prev. Close
69.18
Open
69.5
Day's Range
69.22-72.98
52 wk Range
43.86-74.72
Volume
1.1M
Average Volume (3m)
720K
1-Year Change
53.9015%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SDZ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
71.04
Downside
-2.38%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Sandoz Group AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

7 Buy
8 Hold
1 Sell
Ratings:
16 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 71.04
(-2.38% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy81.00+11.29%75.00Maintain01/07/2026
Jefferies
Buy84.00+15.42%81.00Maintain05/05/2026
Barclays
Buy75.00+3.05%-Upgrade05/05/2026
Deutsche Bank
Hold65.00-10.69%70.00Maintain29/04/2026
JPMorgan
Buy75.00+3.05%66.00Maintain14/04/2026

Sandoz Group AG Earnings Call Summary for Q3/2025

  • Sandoz reported 6% net sales growth in Q3 2025, with biosimilars segment surging 13%, leading to an upgraded full-year core EBITDA margin guidance of 21-22%
  • The company launched 115 new medicines in the first nine months of 2025, with Europe remaining its strongest market (>50% of sales)
  • Biosimilars now account for 31% of net sales, reflecting the company's strategic pivot that CEO Richard Saynor described as 'excellent progress'
  • Despite 3% price erosion, Sandoz projects EPS of $3.31 for FY2025 and $3.89 for FY2026, with revenue forecasts of $11.07B and $11.9B respectively
  • The stock trades near its 52-week high of $66.20 after gaining 41.6% over six months, though InvestingPro data suggests it may be overvalued
Last Updated: 30/10/2025, 09:28
Read Full Transcript

Earnings

Latest Release
05/08/2026
EPS / Forecast
0.25 / --
Revenue / Forecast
5.78B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.47%
Dividend Yield
1.16%
Industry Median 2.18%
Annualised payout
0.80
Paid annually
5-Years Growth
-
Growth Streak

Sandoz (SDZ) Income Statement & Profits

Compare SDZ to Peers and Sector

Metrics to compare
SDZ
Peers
Sector
Relationship
P/E Ratio
60.4x24.5x−0.4x
PEG Ratio
0.33−0.080.00
Price/Book
4.3x2.7x2.6x
Price / LTM Sales
3.3x3.2x3.1x
Upside (Analyst Target)
0.4%4.3%48.8%
Fair Value Upside
Unlock13.7%5.7%Unlock

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

Employees
20000

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
145.97M33.73%10.62B
Other Institutional Investors
46.43M10.73%3.38B
Public Companies & Retail Investors
240.30M55.54%17.49B
Total
432.69M100.00%31.49B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
UBS Asset Management AG6.47%27,984,0002,036,676
BlackRock, Inc.6.15%26,589,7361,935,201

People Also Watch

732.40
PGHN
+1.38%
671.86
PWR
+0.60%
990.32
GEV
-1.00%
81.76
ABBN
-0.68%
593.20
ZURN
+0.71%

FAQ

What Is the Sandoz (Switzerland: SDZ) Share Price Today?

The Sandoz stock price today is 72.78 CHF.

What Stock Exchange Does Sandoz (SDZ) Trade On?

Sandoz is listed and trades on the Switzerland Stock Exchange.

What Is the Ticker (Stock Symbol) for Sandoz?

The stock symbol (also called a 'ticker') for Sandoz is "SDZ."

Does Sandoz Pay Dividends? What’s The Current SDZ Dividend Yield?

Yes, SDZ Pays Dividends to its Shareholders. The current Sandoz dividend yield is 1.16%.

What Is the Current Sandoz Market Capitalisation?

As of today, Sandoz (Switzerland: SDZ) market cap is 31.49B CHF.

What Is Sandoz's (SDZ) Earnings Per Share (TTM)?

The Sandoz EPS is currently 1.47 (Trailing Twelve Months).

Is SDZ a Buy or Sell From a Technical Analyst Perspective?

Based on today's Sandoz moving averages and other technical indicators, the daily buy/sell signal for SDZ stock is Strong Buy.

How Many Times Has Sandoz Stock Split?

Sandoz has split 0 times. (See the SDZ stock split history page for full effective split date and price information.)

How Many Employees Does Sandoz Have?

Sandoz has 20000 employees, based on their latest Companies House report.

What is the current trading status of Sandoz (Switzerland: SDZ)?

As of 09/08/2026, Sandoz (SDZ) is trading at a share price of 72.78 CHF, with a previous close of 69.18 CHF. The stock has fluctuated within a day range of 69.22 CHF to 72.98 CHF, while its 52-week range spans from 43.86 CHF to 74.72 CHF.

What Is Sandoz (SDZ) Price Target According to Analysts?

The average 12-month price target for Sandoz is 71.04 CHF, with a high estimate of 81.88671622 CHF and a low estimate of 55.3854234 CHF. 7 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -2.38% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.